Medifocus Announces, Its Company Information Has Been Accepted To Be Available Through Standard & Poor’s Market Access Program

COLUMBIA, Md.--(BUSINESS WIRE)--Medifocus Inc. (OTC:MDFZF.PK and TSXV:MFS) a medical device company currently in Phase III clinical studies for the treatment of Breast Cancer, is pleased to announce that its company information will be made available via Standard & Poor's Market Access Program, an information distribution service that enables subscribing publicly traded companies to have their company information disseminated to users of Standard & Poor's Advisor Insight. The company information to be made available through this program includes share price, volume, dividends, shares outstanding, company financial position, and earnings. Standard & Poor's Advisor Insight is an Internet-based research engine used by more than 100,000 investment advisors. A public version of the site is available at www.advisorinsight.com.